BMC cancer
Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer.
David Easty, Ray McDermott, Adrian G Murphy, Liam Grogan, Patrick G Morris, Oscar S Breathnach, Keith Egan, Sinead Toomey, Anne Horgan, Derek Power, Nemer Osman, Imelda Parker, Vicky Donachie, Anna Shevlin, Aisling Barrett
Published: 202610.1186/s12885-025-14512-2
No abstract available for this study.